A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Haemonetics Corp stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 3,065 shares of HAE stock, worth $209,308. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,065
Holding current value
$209,308
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$72.45 - $91.58 $222,059 - $280,692
3,065 New
3,065 $246,000
Q1 2023

May 15, 2023

BUY
$72.75 - $90.6 $1.19 Million - $1.48 Million
16,353 New
16,353 $1.35 Million
Q1 2020

May 15, 2020

SELL
$74.34 - $121.82 $511,905 - $838,852
-6,886 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$114.37 - $129.46 $408,987 - $462,948
3,576 Added 108.04%
6,886 $791,000
Q3 2019

Nov 14, 2019

BUY
$117.16 - $138.52 $387,799 - $458,501
3,310 New
3,310 $418,000
Q2 2019

Aug 14, 2019

SELL
$81.74 - $120.34 $2.27 Million - $3.34 Million
-27,729 Closed
0 $0
Q1 2019

May 15, 2019

BUY
$83.25 - $102.12 $1.24 Million - $1.52 Million
14,886 Added 115.91%
27,729 $2.43 Million
Q4 2018

Feb 14, 2019

BUY
$90.66 - $116.63 $562,635 - $723,805
6,206 Added 93.51%
12,843 $1.29 Million
Q3 2018

Nov 14, 2018

SELL
$89.96 - $114.58 $2.52 Million - $3.22 Million
-28,066 Reduced 80.87%
6,637 $760,000
Q2 2018

Aug 14, 2018

BUY
$71.53 - $95.75 $1.32 Million - $1.77 Million
18,456 Added 113.6%
34,703 $3.11 Million
Q1 2018

May 15, 2018

BUY
$60.72 - $74.41 $134,191 - $164,446
2,210 Added 15.74%
16,247 $1.19 Million
Q4 2017

Feb 14, 2018

SELL
$44.96 - $58.99 $387,645 - $508,611
-8,622 Reduced 38.05%
14,037 $815,000
Q3 2017

Nov 14, 2017

BUY
$40.38 - $44.87 $914,970 - $1.02 Million
22,659
22,659 $1.02 Million

Others Institutions Holding HAE

About HAEMONETICS CORP


  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.5B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track Paul Tudor Jones's Portfolio

Track Paul Tudor Jones Portfolio

Follow Paul Tudor Jones (Tudor Investment Corp Et Al) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tudor Investment Corp Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Tudor Investment Corp Et Al and Paul Tudor Jones with notifications on news.